Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Sees Large Drop in Short Interest

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWMGet Free Report) was the target of a large decline in short interest in the month of December. As of December 31st, there was short interest totalling 100 shares, a decline of 75.0% from the December 15th total of 400 shares. Based on an average trading volume of 3,100 shares, the days-to-cover ratio is currently 0.0 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price Performance

Shares of HROWM stock traded up $0.18 during mid-day trading on Tuesday, hitting $26.94. 2,544 shares of the company’s stock were exchanged, compared to its average volume of 4,368. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a fifty-two week low of $25.29 and a fifty-two week high of $27.72. The stock has a 50-day simple moving average of $26.26 and a two-hundred day simple moving average of $26.36.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Wednesday, January 15th will be paid a dividend of $0.7422 per share. This represents a $2.97 annualized dividend and a yield of 11.02%. The ex-dividend date is Wednesday, January 15th.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

(Get Free Report)

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.

See Also

Receive News & Ratings for Harrow Health Inc. 11.875% Senior Notes due 2027 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harrow Health Inc. 11.875% Senior Notes due 2027 and related companies with MarketBeat.com's FREE daily email newsletter.